Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (251-260 of 519) with videos related to

Pageof 52
Sort By:
Blood Advances|January 4, 2018
The impact of prior malignancies on second malignancies and survival in MM patients: a population-based studyGudbjörg Jonsdottir, Sigrún H Lund, Magnus Björkholm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based studyMalin Hultcrantz, Sigurdur Yngvi Kristinsson, Therese M-L Andersson, et al.
Blood|July 9, 2010
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based studySigurdur Y Kristinsson, Min Tang, Ruth M Pfeiffer, et al.
Haematologica|July 11, 2015
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 yearsMonika Engelhardt, Gabriele Ihorst, Ola Landgren, et al.
Leukemia & Lymphoma|November 23, 2013
The proteasome: mechanisms of biology and markers of activity and response to treatment in multiple myelomaElisabet E Manasanch, Neha Korde, Adriana Zingone, et al.
Blood|December 4, 2004
High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphomaErik Björck, Sara Ek, Ola Landgren, et al.
Nature Reviews. Urology|July 29, 2022
Mutagenic effect of chemotherapy on sperm DNA and implications for family planningAri P Bernstein, Justin Loloi, Rohit Reddy, et al.
Annals of Hematology|May 18, 2013
Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseasesRajiv Shah, Bram Stieltjes, Mindaugas Andrulis, et al.
Plos One|October 27, 2025
Machine learning reveals distinct T-cell receptor clusters in plasma cell dyscrasias compared to healthy controlsDavid G Coffey, Yong Zhang, Elizabeth Hill, et al.
JAMA Oncology|July 17, 2015
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple MyelomaElin Edda Sigurdardottir, Ingemar Turesson, Sigrun Helga Lund, et al.
Pageof 52

Showing results (251-260 of 519) with videos related to

Sort By:
Pageof 52
Blood Advances|January 4, 2018
The impact of prior malignancies on second malignancies and survival in MM patients: a population-based studyGudbjörg Jonsdottir, Sigrún H Lund, Magnus Björkholm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012
Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based studyMalin Hultcrantz, Sigurdur Yngvi Kristinsson, Therese M-L Andersson, et al.
Blood|July 9, 2010
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based studySigurdur Y Kristinsson, Min Tang, Ruth M Pfeiffer, et al.
Haematologica|July 11, 2015
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 yearsMonika Engelhardt, Gabriele Ihorst, Ola Landgren, et al.
Leukemia & Lymphoma|November 23, 2013
The proteasome: mechanisms of biology and markers of activity and response to treatment in multiple myelomaElisabet E Manasanch, Neha Korde, Adriana Zingone, et al.
Blood|December 4, 2004
High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphomaErik Björck, Sara Ek, Ola Landgren, et al.
Nature Reviews. Urology|July 29, 2022
Mutagenic effect of chemotherapy on sperm DNA and implications for family planningAri P Bernstein, Justin Loloi, Rohit Reddy, et al.
Annals of Hematology|May 18, 2013
Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseasesRajiv Shah, Bram Stieltjes, Mindaugas Andrulis, et al.
Plos One|October 27, 2025
Machine learning reveals distinct T-cell receptor clusters in plasma cell dyscrasias compared to healthy controlsDavid G Coffey, Yong Zhang, Elizabeth Hill, et al.
JAMA Oncology|July 17, 2015
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple MyelomaElin Edda Sigurdardottir, Ingemar Turesson, Sigrun Helga Lund, et al.
Pageof 52